Prophylaxis of erectile function after radical prostatectomy with phosphodiesterase type 5 inhibitors

Current Pharmaceutical Design

Volumn 15, Issue 30, 2009, Pages 3496-3501

  Deho, F ^a   Gallina, A ^a   Salonia, A ^a   Briganti, A ^a   Suardi, N ^a   Zanni, G ^a   Guazzoni, G ^a   Rigatti, P ^a   Montorsi, F ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Erectile dysfunction; Phosphodiesterase 5 inhibitors; Radical prostatectomy

Indexed keywords

CYCLIC GMP; METHYLPREDNISOLONE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; VARDENAFIL;

CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EDEMA; ENZYME ACTIVATION; ERECTILE DYSFUNCTION; EVENING DOSAGE; FIBROSIS; HUMAN; INFLAMMATION; LOW DRUG DOSE; NONHUMAN; PENIS ERECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; REHABILITATION CARE; REVIEW; SEXUAL INTERCOURSE; SMOOTH MUSCLE RELAXATION; VEIN OCCLUSION;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ERECTILE DYSFUNCTION; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY;

EID: 70449367110     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789206999     Document Type: Review

References (76)

1. Oliver SE, Donovan JL, Peters TJ, Frankel S, Hamdy FC, Neal DE. Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU Int 2003; 91: 331-336 (Pubitemid 36359636)
2. Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol 2004; 171: 1393-1401
3. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, et al. European Association of Urology. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68-80.
4. Heidenreich A. Radical prostatectomy in 2007: oncologic control and preservation of functional integrity. Eur Urol 2008; 53: 877-879
5. Eggener SE, Guillonneau B. Laparoscopic radical prostatectomy: ten years later, time for evidence-based foundation. Eur Urol 2008; 54: 4-7.
6. Ficarra V, Cavalleri S, Novara G, Aragona M, Artibani W. Evidence from robot-assisted laparoscopic radical prostatectomy: a systematic review. Eur Urol 2007; 51: 45-55.
7. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR. Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 1999; 53: 180-186
8. Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality of life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001; 19: 1619-1628 (Pubitemid 32230861)
9. Scales CD Jr, Moul JW, Curtis LH, Elkin EP, Hughes ME, Carroll PR. CaPSURE Investigators. Prostate cancer in the Baby Boomer generation: results from CaPSURE. Urology 2007; 70: 1162-1167
10. Glina S. How much are patients interested in erectile dysfunction treatment after radical prostatectomy? Eur Urol 2008; 53: 461-462
11. Bianco FJ Jr, Scardino PT, Eastham JA. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta" ). Urology 2005; 66(5 Suppl): 83-94.
12. Eastham JA, Scardino PT, Kattan MW. Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. J Urol 2008; 179: 2207-2210
13. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000; 283: 354-360 (Pubitemid 30051753)
14. Schover LR, Fouladi RT, Warneke CL, Neese L, Klein EA, Zippe C, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002; 95: 1773-1785
15. Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S, Currie K, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol 2005; 174: 2105-2110 (Pubitemid 41611746)
16. Dubbelman YD, Dohle GR, Schröder FH. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol 2006; 50: 711-718
17. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261
18. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448-457 (Pubitemid 351167753)
19. Briganti A, Salonia A, Gallina A, Chun FK, Karakiewicz PI, Graefen M, et al. Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 2007; 25: 143-148
20. Salonia A, Zanni G, Gallina A, Saccà A, Sangalli M, Naspro R, et al. Baseline potency in patients candidates to bilateral nerve sparing radical retropubic prostatectomy. Eur Urol 2006; 50: 360-365 (Pubitemid 44038061)
21. Michl UH, Friedrich MG, Graefen M, Haese A, Heinzer H, Huland H. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. J Urol 2006; 176: 227-231 (Pubitemid 43815418)
22. Salonia A, Gallina A, Briganti A, Zanni G, Saccà A, Dehò F, et al. Remembered International Index of Erectile Function domain scores are not accurate in assessing preoperative potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. J Sex Med 2008; 5: 677-683 (Pubitemid 351337895)
23. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45:123-133 (Pubitemid 38147816)
24. Montorsi F, Salonia A, Suardi N, Gallina A, Zanni G, Briganti A, et al. Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy. Eur Urol 2005; 48: 938-945 (Pubitemid 41641640)
25. Graefen M, Walz J, Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur Urol 2006; 49: 38-48. (Pubitemid 41789952)
26. Zorn KC, Gofrit ON, Orvieto MA, Mikhail AA, Zagaja GP, Shalhav AL. Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation. Eur Urol 2007; 51: 755-762
27. Menon M, Shrivastava A, Kaul S, Badani KK, Fumo M, Bhandari M, et al. Vattikuti Institute prostatectomy: contemporary technique and analysis of results. Eur Urol 2007; 51: 648-657 (Pubitemid 46097286)
28. Stolzenburg JU, Rabenalt R, Do M, Schwalenberg T, Winkler M, Dietel A, et al. Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy. Eur Urol 2008; 53: 931-940
29. Costello AJ, Brooks M, Cole OJ. Anatomical studies of the neurovascular bundle and cavernosal nerves. BJU Int 2004; 94: 1071-1076 (Pubitemid 39577096)
30. Lunacek A, Schwentner C, Fritsch H, Bartsch G, Strasser H. Anatomical radical retropubic prostatectomy: 'curtain dissection' of the neurovascular bundle. BJU Int 2005; 95(9): 1226-1231
31. Tewari A, Takenaka A, Mtui E, Horninger W, Peschel R, Bartsch G, et al. The proximal neurovascular plate and the tri-zonal neural architecture around the prostate gland: importance in the athermal robotic technique of nerve-sparing prostatectomy. BJU Int 2006; 98: 314-323
32. Eichelberg C, Erbersdobler A, Michl U, Schlomm T, Salomon G, Graefen M, et al. Nerve distribution along the prostatic capsule. Eur Urol 2007; 51: 105-110
33. Ganzer R, Blana A, Gaumann A, Stolzenburg JU, Rabenalt R, Bach T, et al. Topographical anatomy of periprostatic and capsular nerves: quantification and computerised planimetry. Eur Urol 2008; 54: 353-361
34. Gianduzzo TR, Colombo JR, El-Gabry E, Haber GP, Gill IS. Anatomical and electrophysiological assessment of the canine periprostatic neurovascular anatomy: perspectives as a nerve sparing radical prostatectomy model. J Urol 2008; 179: 2025-2029
35. Masterson TA, Serio AM, Mulhall JP, Vickers AJ, Eastham JA. Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function. BJU Int 2008; 101: 1217-1222
36. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, et al. Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371-1375 (Pubitemid 34132096)
37. Mulhall JP, Secin FP, Guillonneau B. Artery sparing radical prostatectomy-myth or reality? J Urol 2008; 179: 827-831
38. Secin FP, Touijer K, Mulhall J, Guillonneau B. Anatomy and preservation of accessory pudendal arteries in laparoscopic radical prostatectomy. Eur Urol 2007; 51: 1229-1235 (Pubitemid 46436288)
39. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239-245
40. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175-1179
41. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673-1676 (Pubitemid 40524802)
42. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabè J, Burgess G, et al. Chronic sildenafil improves erectile function and endothelium-dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 2005; 47: 87-91. (Pubitemid 39575722)
43. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, et al. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008; 101: 203-210 (Pubitemid 350294044)
44. Vignozzi L, Filippi S, Morelli A, Ambrosini S, Luconi M, Vannelli GB, et al. Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. J Sex Med 2006; 3: 419-431
45. Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, et al. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. IJIR 2008; 20: 60-67
46. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez- Cadavid NF, Rajfer J. Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006; 68: 429-435 (Pubitemid 44175524)
47. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol 2008; 179(2): 779-785
48. Schwartz EJ, Wong P, Graydon J. Sildenafil preserves intracorporeal smooth muscle after radical retropubis prostatectomy. J Urol 2004; 171: 771-774 (Pubitemid 38090480)
49. Parsons JK, Marschke P, Maples P, Walsh PC. Effect of methylprednisolone on return of sexual function after nerve-sparing radical retropubic prostatectomy. Urology 2004; 64: 987-990 (Pubitemid 39469519)
50. Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the surveillance, epidemiology, and end results prostate cancer outcomes study. J Urol 2005; 174: 646-650 (Pubitemid 40981623)
51. Matthew AG, Goldman A, Trachtenberg J, Robinson J, Horsburgh S, Currie K, et al. Sexual dysfunction after radical prostatectomy: prevalence, treatments, restricted use of treatments and distress. J Urol 2005; 174: 2105-2110 (Pubitemid 41611746)
52. Giuliano F, Amar E, Chevallier D, Montaigne O, Joubert JM, Chartier-Kastler E. How urologists manage erectile dysfunction after radical prostatectomy: a national survey (REPAIR) by the French urological association. J Sex Med 2008; 5: 448-457 (Pubitemid 351167753)
53. Raina R, Pahlajani G, Agarwal A, Zippe CD. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity. BJU Int 2007; 100: 1317-1321 (Pubitemid 350043898)
54. Lane BR, Abouassaly R, Angermeier KW, Montague DK. Threepiece inflatable penile prostheses can be safely implanted after radical prostatectomy through a transverse scrotal incision. Urology 2007; 70: 539-542 (Pubitemid 47464480)
55. Bianco F, Kattan M, Eastham J. Surgeon and surgical volume as predictors of erectile function outcomes following radical prostatectomy. J Sex Med 2004; 1(Suppl 1): 33.
56. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS. Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int 2008; 101: 833-836 (Pubitemid 351347727)
57. Hollenbeck BK, Dunn RL, Wei JT, Montie JE, Sanda MG. Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument. J Urol 2003; 169: 1453-1457
58. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomised trial. J Urol 1997; 158: 1408-1410 (Pubitemid 27391208)
59. Brock G, Tu LM, Linet OI. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001; 57: 536-541 (Pubitemid 32192987)
60. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005; 2: 532-545 (Pubitemid 40975838)
61. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, et al. Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 2006; 18: 77-81. (Pubitemid 43050026)
62. Raina R, Lakin MM, Agarwal A, Mascha E, Montagne DK, Klein E, et al. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy. Urology 2004; 63: 960-966 (Pubitemid 38596687)
63. Zippe CD, Jhaveri FM, Klein EA, Kedia S, Pasqualotto FF, Kedia A, et al. Role of Viagra after radical prostatectomy. Urology 2000; 55(2): 241-245
64. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000; 56(4): 631-634 (Pubitemid 30706239)
65. Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003; 62: 110-115 (Pubitemid 36802082)
66. Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004; 172: 1036-1041 (Pubitemid 39096457)
67. Brock G, Nehra A, Lipshultz LI, Karlin GS, Gleave M, Seger M, et al. Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy. J Urol 2003; 170: 1278-1283 (Pubitemid 37108132)
68. Nehera A, Grantmyre J, Nadel A, Thibonnier M, Brock G. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy. J Urol 2005; 173: 2067-2071 (Pubitemid 40675245)
69. Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, et al. Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 2000; 56: 906-911
70. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008; 101: 1279-1283 (Pubitemid 351549634)
71. Padma-Nathan H, McCullough AR, Giuliano F, Toler SM, Wohlhuter C. Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy. J Urol 2003; 4 (Suppl): 375.
72. Gallo L, Perdona S, Autorino R, Celentano E, Menna L, Di Lorenzo G, et al. Recovery of erection after pelvic urologic surgery: our experience. Int J Impot Res 2005; 17: 484. (Pubitemid 41581699)
73. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008; 54(4): 924-931
74. Aversa A, Caprio M, Rosano GM, Spera G. Endothelial effects of drugs designed to treat erectile dysfunction. Curr Pharm Des 2008; 14(35): 3768-3778
75. Caprio M, Mammi C, Jaffe IZ, Zennaro MC, Aversa A, et al. The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction. Curr Pharm Des 2008; 14(35): 3749-3757
76. Shindel AW, Kishore S, Lue TF. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des 2008; 14(35): 3758-3767